Top Stories

Industry Insights: Pivot to Growth - Jim Margaritis - Vice President, APAC Cluster Head and General Manager Australia and New Zealand Teva Pharmaceuticals.

2024 Year in Review: A Year of Growth and Innovation

Teva’s 2023 Healthy Future Report

Covid 19 virus

Coronavirus (COVID-19) Teva Australia

Teva logo

Update Regarding COVID-19

product shelves

Teva Signs New $2.3 Billion Syndicated Revolving Credit Facility

a young patient receives chemotherapy at the Black Lion Hospital in Addis Ababa, Photo courtesy of the Access to Childhood Cancer Essentials( ACCESS) Initiative

Moving at light speed

team meeting

Media Inquiries